Literature DB >> 23780749

Genetic profiles in ischaemic stroke.

Steve Bevan1, Hugh S Markus.   

Abstract

Stroke represents a clinical syndrome rather than a single disease. A number of stroke subtypes can be distinguished based on careful phenotyping, with each of these having distinct and overlapping risk factor profiles. Recent evidence has suggested that genetics plays an important part in stroke risk, with at least 2 genes specific to stroke risk directly now having been identified. This review will explore our current understanding of the genetics underlying stroke risk and whether this information is currently useful in a clinical setting for patient benefit.

Entities:  

Mesh：

Year:  2013        PMID： 23780749     DOI： 10.1007/s11883-013-0342-8

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


  51 in total

1.  Pharmacogenetics of coumarinic oral anticoagulants.

Authors:  Vangelis G Manolopoulos; Georgia Ragia; Anna Tavridou
Journal:  Pharmacogenomics       Date:  2010-04       Impact factor: 2.533

2.  Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins.

Authors:  D Carmelli; C DeCarli; G E Swan; L M Jack; T Reed; P A Wolf; B L Miller
Journal:  Stroke       Date:  1998-06       Impact factor: 7.914

3.  Infarcts of undetermined cause: the NINCDS Stroke Data Bank.

Authors:  R L Sacco; J H Ellenberg; J P Mohr; T K Tatemichi; D B Hier; T R Price; P A Wolf
Journal:  Ann Neurol       Date:  1989-04       Impact factor: 10.422

4.  Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction, stroke, and death in patients with or without previous stroke: a nationwide cohort study.

Authors:  Jonas Bjerring Olesen; Steen Zabell Abildstrøm; Jesper Erdal; Gunnar H Gislason; Peter Weeke; Charlotte Andersson; Christian Torp-Pedersen; Peter Riis Hansen
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-07-18       Impact factor: 2.890

5.  Complement factor H polymorphism and age-related macular degeneration.

Authors:  Albert O Edwards; Robert Ritter; Kenneth J Abel; Alisa Manning; Carolien Panhuysen; Lindsay A Farrer
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

Review 6.  Genetics and ischaemic stroke.

Authors:  A Hassan; H S Markus
Journal:  Brain       Date:  2000-09       Impact factor: 13.501

7.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

8.  Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke.

Authors:  Solveig Gretarsdottir; Gudmar Thorleifsson; Andrei Manolescu; Unnur Styrkarsdottir; Anna Helgadottir; Andreas Gschwendtner; Konstantinos Kostulas; Gregor Kuhlenbäumer; Steve Bevan; Thorbjorg Jonsdottir; Hjordis Bjarnason; Jona Saemundsdottir; Stefan Palsson; David O Arnar; Hilma Holm; Gudmundur Thorgeirsson; Einar Mar Valdimarsson; Sigurlaug Sveinbjörnsdottir; Christian Gieger; Klaus Berger; H-Erich Wichmann; Jan Hillert; Hugh Markus; Jeffrey Robert Gulcher; E Bernd Ringelstein; Augustine Kong; Martin Dichgans; Daniel Fannar Gudbjartsson; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Ann Neurol       Date:  2008-10       Impact factor: 10.422

9.  Genetic variation in white matter hyperintensity volume in the Framingham Study.

Authors:  Larry D Atwood; Philip A Wolf; Nancy L Heard-Costa; Joseph M Massaro; Alexa Beiser; Ralph B D'Agostino; Charles DeCarli
Journal:  Stroke       Date:  2004-05-13       Impact factor: 7.914

10.  Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.

Authors:  Hans-Christoph Diener; Ralph L Sacco; Salim Yusuf; Daniel Cotton; Stephanie Ounpuu; William A Lawton; Yuko Palesch; Reneé H Martin; Gregory W Albers; Philip Bath; Natan Bornstein; Bernard P L Chan; Sien-Tsong Chen; Luis Cunha; Björn Dahlöf; Jacques De Keyser; Geoffrey A Donnan; Conrado Estol; Philip Gorelick; Vivian Gu; Karin Hermansson; Lutz Hilbrich; Markku Kaste; Chuanzhen Lu; Thomas Machnig; Prem Pais; Robin Roberts; Veronika Skvortsova; Philip Teal; Danilo Toni; Cam VanderMaelen; Thor Voigt; Michael Weber; Byung-Woo Yoon
Journal:  Lancet Neurol       Date:  2008-08-29       Impact factor: 44.182
View more
  4 in total

Review 1.  Endothelial cells and human cerebral small vessel disease.

Authors:  Atticus H Hainsworth; Asho T Oommen; Leslie R Bridges
Journal:  Brain Pathol       Date:  2015-01       Impact factor: 6.508

2.  A Decrease of Brain MicroRNA-122 Level Is an Early Marker of Cerebrovascular Disease in the Stroke-Prone Spontaneously Hypertensive Rat.

Authors:  Rosita Stanzione; Franca Bianchi; Maria Cotugno; Simona Marchitti; Maurizio Forte; Carla Busceti; Larisa Ryskalin; Francesco Fornai; Massimo Volpe; Speranza Rubattu
Journal:  Oxid Med Cell Longev       Date:  2017-06-18       Impact factor: 6.543

3.  CYP3A4 and CYP11A1 variants are risk factors for ischemic stroke: a case control study.

Authors:  Ning Gao; Hong Tang; Ling Gao; Guolong Tu; Han Luo; Ying Xia
Journal:  BMC Neurol       Date:  2020-03-04       Impact factor: 2.474

4.  Single-Nucleotide Polymorphisms in Oxidative Stress-Related Genes and the Risk of a Stroke in a Polish Population-A Preliminary Study.

Authors:  Ewelina Synowiec; Paulina Wigner; Natalia Cichon; Cezary Watala; Piotr Czarny; Joanna Saluk-Bijak; Elzbieta Miller; Tomasz Sliwinski; Ewa Zielinska-Nowak; Michal Bijak
Journal:  Brain Sci       Date:  2021-03-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.